Home Other Building Blocks (8S,9S,10R,13S,14S,17R)-17-((2S,3R)-3-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

(8S,9S,10R,13S,14S,17R)-17-((2S,3R)-3-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

CAS No.:
17954-98-2
Catalog Number:
AG002734
Molecular Formula:
C27H46O2
Molecular Weight:
402.6529
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
≥98%
1 week
United States
$123
- +
5mg
≥98%
1 week
United States
$357
- +
10mg
≥98%
1 week
United States
$590
- +
Product Description
Catalog Number:
AG002734
Chemical Name:
(8S,9S,10R,13S,14S,17R)-17-((2S,3R)-3-Hydroxy-6-methylheptan-2-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol
CAS Number:
17954-98-2
Molecular Formula:
C27H46O2
Molecular Weight:
402.6529
MDL Number:
MFCD00070042
IUPAC Name:
(3S,8S,9S,10R,13S,14S,17R)-17-[(2S,3R)-3-hydroxy-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol
InChI:
InChI=1S/C27H46O2/c1-17(2)6-11-25(29)18(3)22-9-10-23-21-8-7-19-16-20(28)12-14-26(19,4)24(21)13-15-27(22,23)5/h7,17-18,20-25,28-29H,6,8-16H2,1-5H3/t18-,20-,21-,22+,23-,24-,25+,26-,27+/m0/s1
InChI Key:
RZPAXNJLEKLXNO-GFKLAVDKSA-N
SMILES:
CC(CC[C@H]([C@H]([C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2CC=C2[C@]1(C)CC[C@@H](C2)O)C)O)C
Properties
Complexity:
624  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0
Exact Mass:
402.35g/mol
Formal Charge:
0
Heavy Atom Count:
29  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
402.663g/mol
Monoisotopic Mass:
402.35g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
40.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
7  
Literature
Title Journal
Expression of CYP4V2 in human THP1 macrophages and its transcriptional regulation by peroxisome proliferator-activated receptor gamma. Toxicology and applied pharmacology 20170901
In vivo production of novel vitamin D2 hydroxy-derivatives by human placentas, epidermal keratinocytes, Caco-2 colon cells and the adrenal gland. Molecular and cellular endocrinology 20140305
Cisplatin inhibits testosterone synthesis by a mechanism that includes the action of reactive oxygen species (ROS) at the level of P450scc. Chemico-biological interactions 20120930
LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast cancer cells: relation to proliferation and apoptosis. Anticancer research 20120701
Dietary supplementation with 22-S-hydroxycholesterol to rats reduces body weight gain and the accumulation of liver triacylglycerol. Lipids 20120501
Liver X receptor activation downregulates organic anion transporter 1 (OAT1) in the renal proximal tubule. American journal of physiology. Renal physiology 20120301
The liver X receptor modulator 22(S)-hydroxycholesterol exerts cell-type specific effects on lipid and glucose metabolism. The Journal of steroid biochemistry and molecular biology 20120201
A steroid isolated from the water mold Achlya heterosexualis induces neurogenesis in vitro and in vivo. Steroids 20120201
Caprospinol: discovery of a steroid drug candidate to treat Alzheimer's disease based on 22R-hydroxycholesterol structure and properties. Journal of neuroendocrinology 20120101
Simvastatin reduces steroidogenesis by inhibiting Cyp17a1 gene expression in rat ovarian theca-interstitial cells. Biology of reproduction 20120101
Regulation of LXR by fatty acids, insulin, growth hormone and tumor necrosis factor-α in rainbow trout myocytes. Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 20111001
Dysregulation of SREBP2 induces BACE1 expression. Neurobiology of disease 20111001
The human placenta expresses CYP17 and generates androgens de novo. The Journal of clinical endocrinology and metabolism 20110501
Structural basis for three-step sequential catalysis by the cholesterol side chain cleavage enzyme CYP11A1. The Journal of biological chemistry 20110218
Oxysterols inhibit differentiation and fusion of term primary trophoblasts by activating liver X receptors. Placenta 20110201
Antiproliferative effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on multiple human cancer cell lines. Anticancer research 20100901
Identification of a naturally occurring rexinoid, honokiol, that activates the retinoid X receptor. Journal of natural products 20100827
Testosterone synthesized in cultured human SZ95 sebocytes derives mainly from dehydroepiandrosterone. Experimental dermatology 20100501
Mesenchymal stem cells differentiate into renin-producing juxtaglomerular (JG)-like cells under the control of liver X receptor-alpha. The Journal of biological chemistry 20100416
LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. Atherosclerosis 20091101
Effects of cholesterol and cAMP on progesterone production in cultured luteal cells isolated from pseudopregnant cat ovaries. Animal reproduction science 20091001
Mechanism underlying apolipoprotein E (ApoE) isoform-dependent lipid efflux from neural cells in culture. Journal of neuroscience research 20090815
OSBP-related protein 2 is a sterol receptor on lipid droplets that regulates the metabolism of neutral lipids. Journal of lipid research 20090701
Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis. Experimental dermatology 20090701
Highly sensitive quantification of key regulatory oxysterols in biological samples by LC-ESI-MS/MS. Journal of lipid research 20090201
Transport-metabolism interplay: LXRalpha-mediated induction of human ABC transporter ABCC2 (cMOAT/MRP2) in HepG2 cells. Molecular pharmaceutics 20090101
Androgen deprivation by activating the liver X receptor. Endocrinology 20080801
Epoxycholesterol impairs cholesteryl ester hydrolysis in macrophage foam cells, resulting in decreased cholesterol efflux. Arteriosclerosis, thrombosis, and vascular biology 20080601
Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development. Bioorganic & medicinal chemistry 20080415
Expression and biological activity of ABCA1 in alveolar epithelial cells. American journal of respiratory cell and molecular biology 20080301
Fenvalerate inhibits progesterone production through cAMP-dependent signal pathway. Toxicology letters 20080104
22R-Hydroxycholesterol induces differentiation of human NT2 precursor (Ntera2/D1 teratocarcinoma) cells. Neuroscience 20070824
Monobutyl phthalate inhibits steroidogenesis by downregulating steroidogenic acute regulatory protein expression in mouse Leydig tumor cells (MLTC-1). Journal of toxicology and environmental health. Part A 20070601
22-Hydroxycholesterols regulate lipid metabolism differently than T0901317 in human myotubes. Biochimica et biophysica acta 20061201
Sesquiterpene lactone helenalin suppresses Leydig and adrenocortical cell steroidogenesis by inhibiting expression of the steroidogenic acute regulatory protein. Reproductive toxicology (Elmsford, N.Y.) 20061101
Energized, polarized, and actively respiring mitochondria are required for acute Leydig cell steroidogenesis. Endocrinology 20060801
Synergistic effect of peroxisome proliferator activated receptor-gamma and liver X receptor-alpha in the regulation of inflammation in macrophages. Shock (Augusta, Ga.) 20060801
HPLC method for quantification and characterization of cholesterol and its oxidation products in eggs. Lipids 20060601
Oxysterol 22(R)-hydroxycholesterol induces the expression of the bile salt export pump through nuclear receptor farsenoid X receptor but not liver X receptor. The Journal of pharmacology and experimental therapeutics 20060401
Carbaryl inhibits basal and FSH-induced progesterone biosynthesis of primary human granulosa-lutein cells. Toxicology 20060301
Suppression of inducible nitric oxide synthase and cyclooxygenase-2 gene expression by 22(R)-hydroxycholesterol requires de novo protein synthesis in activated macrophages. The Journal of steroid biochemistry and molecular biology 20051201
Liver X receptors mediate inhibition of hCG secretion in a human placental trophoblast cell line. Placenta 20051101
Liver X receptor and retinoic X receptor agonists modulate the expression of genes involved in lipid metabolism in human endothelial cells. International journal of molecular medicine 20051001
Osteogenic oxysterols inhibit the adverse effects of oxidative stress on osteogenic differentiation of marrow stromal cells. Journal of cellular biochemistry 20050815
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources. Journal of natural products 20050801
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters. Bioorganic & medicinal chemistry letters 20050602
Effects of fenvalerate on steroidogenesis in cultured rat granulosa cells. Biomedical and environmental sciences : BES 20050401
Regulatory mechanism of Toona sinensis on mouse leydig cell steroidogenesis. Life sciences 20050211
Peripheral-type benzodiazepine receptor-mediated action of steroidogenic acute regulatory protein on cholesterol entry into leydig cell mitochondria. Molecular endocrinology (Baltimore, Md.) 20050201
Cellular physiology of cholesterol efflux in vascular endothelial cells. Circulation 20041102
Rosiglitazone upregulates caveolin-1 expression in THP-1 cells through a PPAR-dependent mechanism. Journal of lipid research 20041101
Evaluation of the role of FSH in regulation of Leydig cell function during different stages of its differentiation. Molecular and cellular endocrinology 20040930
Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. Arteriosclerosis, thrombosis, and vascular biology 20040801
The effect of LXR activators on AP-1 proteins in keratinocytes. The Journal of investigative dermatology 20040701
Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages. Acta pharmacologica Sinica 20040501
Role of p160 coactivator complex in the activation of liver X receptor. Arteriosclerosis, thrombosis, and vascular biology 20040401
Oxysterols regulate expression of the steroidogenic acute regulatory protein. Journal of molecular endocrinology 20040401
Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter. The Journal of biological chemistry 20040312
Verapamil increases the apolipoprotein-mediated release of cellular cholesterol by induction of ABCA1 expression via Liver X receptor-independent mechanism. Arteriosclerosis, thrombosis, and vascular biology 20040301
Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis. Hepatology (Baltimore, Md.) 20040301
Molecular and cellular physiology of apolipoprotein A-I lipidation by the ATP-binding cassette transporter A1 (ABCA1). The Journal of biological chemistry 20040227
Inhibitory actions of lead on steroidogenesis in MA-10 mouse Leydig tumor cells. Archives of andrology 20040101
Identification of naturally occurring spirostenols preventing beta-amyloid-induced neurotoxicity. Steroids 20040101
Oxysterol and 9-cis-retinoic acid stimulate the group IIA secretory phospholipase A2 gene in rat smooth-muscle cells. The Biochemical journal 20031201
Identification and characterization of rodent ABCA1 in isolated type II pneumocytes. American journal of physiology. Lung cellular and molecular physiology 20031001
Induction of intestinal ATP-binding cassette transporters by a phytosterol-derived liver X receptor agonist. The Journal of biological chemistry 20030919
Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling. Molecular endocrinology (Baltimore, Md.) 20030701
Oxysterols suppress constitutive fibrinogen expression. Thrombosis and haemostasis 20030701
Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). The Journal of investigative dermatology 20030601
Regulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesis. FEBS letters 20030522
The inhibitory effects of manganese on steroidogenesis in rat primary Leydig cells by disrupting steroidogenic acute regulatory (StAR) protein expression. Toxicology 20030503
Membrane incorporation of 22-hydroxycholesterol inhibits chemokine receptor activity. Experimental cell research 20030501
22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion. The Journal of biological chemistry 20030411
Formation and functioning of fused cholesterol side-chain cleavage enzymes. DNA and cell biology 20030401
Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Molecular endocrinology (Baltimore, Md.) 20030301
Liver X receptor activators display anti-inflammatory activity in irritant and allergic contact dermatitis models: liver-X-receptor-specific inhibition of inflammation and primary cytokine production. The Journal of investigative dermatology 20030201
Oxysterol-activated LXRalpha/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes. Biochemical and biophysical research communications 20021220
22R-Hydroxycholesterol protects neuronal cells from beta-amyloid-induced cytotoxicity by binding to beta-amyloid peptide. Journal of neurochemistry 20021201
Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol. Journal of lipid research 20021101
ATP-binding cassette transporter 1 participates in LDL oxidation by artery wall cells. Arteriosclerosis, thrombosis, and vascular biology 20021101
Stimulation of progesterone production in human granulosa-lutein cells by lipoproteins: evidence for cholesterol-independent actions of high-density lipoproteins. The Journal of endocrinology 20020401
Alterations in ovarian follicular progesterone secretion by elevated exposures to the drinking water disinfection by-product dibromoacetic acid: examination of the potential site(s) of impact along the steroidogenic pathway. Toxicology 20020227
Macrophage cholesterol efflux to free apoprotein A-I in C3H and C57BL/6 mice. Biochemical and biophysical research communications 20020208
Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency. Biochemical and biophysical research communications 20020118
Oxysterol stimulation of epidermal differentiation is mediated by liver X receptor-beta in murine epidermis. The Journal of investigative dermatology 20020101
Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene. Biochemical and biophysical research communications 20011005
Leukemia inhibitory factor antagonizes gonadotropin induced-testosterone synthesis in cultured porcine leydig cells: sites of action. Endocrinology 20010601
Creation and activity of COS-1 cells stably expressing the F2 fusion of the human cholesterol side-chain cleavage enzyme system. Endocrinology 20010601
Luteinization factor-stimulated steroidogenesis in porcine granulosa cells. General physiology and biophysics 20010601
Pharmacophore analysis of the nuclear oxysterol receptor LXRalpha. Journal of medicinal chemistry 20010315
Genomic sequence and structure of the human ABCG1 (ABC8) gene. Biochemical and biophysical research communications 20010112
The inhibitory effects of lead on steroidogenesis in MA-10 mouse Leydig tumor cells. Life sciences 20010112
Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha). Gene 20010110
Melatonin inhibits the expression of steroidogenic acute regulatory protein and steroidogenesis in MA-10 cells. Journal of andrology 20010101
Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols. Proceedings of the National Academy of Sciences of the United States of America 19970513
Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. The Journal of biological chemistry 19970207
An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 19961024
Properties